Literature DB >> 31039016

Differences in Growth Rate on CT of Adrenal Adenomas and Malignant Adrenal Nodules.

Michael T Corwin1, Shannon M Navarro1, Dania G Malik2, Thomas W Loehfelm1, Ghaneh Fananapazir1, Machelle Wilson3, Michael J Campbell2.   

Abstract

OBJECTIVE. The purpose of this study is to determine the differences in growth rate of adrenal adenomas and malignant adrenal nodules. MATERIALS AND METHODS. This was a retrospective review of adults with an adrenal nodule seen at two different abdominal or chest CT examinations or PET/CT examinations. Patients in the adenoma group were included if they had a CT, MRI, or pathologic diagnosis of an adrenal adenoma. Patients in the malignant group were included if they had a pathologically proven malignant adrenal nodule. Nodule growth was defined as a change in the largest axial diameter greater than or equal to 3 mm. Growth rate was calculated by dividing the change in the longest axial diameter by the time between the first and last imaging examination. RESULTS. There were 105 adenomas and 26 malignant nodules. Of the 105 adenomas, 34 (32.4%; 95% CI, 23.6-42.2%) grew, three (2.9%; 95% CI, 0.6-8.1%) became smaller, and 68 (64.8%; 95% CI, 54.8-73.8%), were unchanged in size. All 26 (100%; 95% CI, 89.1-100%) malignant nodules grew. The mean (± SD) growth rate of adenomas was 1.0 ± 0.67 mm/year (range, 0.3-2.8 mm/year), compared with 58.4 ± 78.5 mm/year (range, 5.8-395.4 mm/year) for malignant nodules (p < 0.001). A growth rate of 3 mm/year distinguished adenomas from malignant nodules with a sensitivity of 100% (95% CI, 86.8-100%) and a specificity of 100% (95% CI, 96.6-100%). CONCLUSION. Approximately one-third of radiologically proven adrenal adenomas grew, all of which grew at a rate less than 3 mm/year. All malignant adrenal nodules grew, and all at a rate greater than 5 mm/year.

Entities:  

Keywords:  adrenal adenoma; adrenal malignancy; growth

Year:  2019        PMID: 31039016     DOI: 10.2214/AJR.19.21342

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Elevated 131I-MIBG activity in adrenocortical adenoma-what other imaging options do we have?

Authors:  Xiaotian Xia; Keshan Wang; Fuqiang Shao; Fan Hu; Shengqing Hu; Yu Dai; Yongxue Zhang; Xiaoli Lan
Journal:  Quant Imaging Med Surg       Date:  2022-04

Review 2.  Quantitative dual-energy CT techniques in the abdomen.

Authors:  Giuseppe V Toia; Achille Mileto; Carolyn L Wang; Dushyant V Sahani
Journal:  Abdom Radiol (NY)       Date:  2021-09-01

Review 3.  Adrenal Mass Characterization in the Era of Quantitative Imaging: State of the Art.

Authors:  Maxime Barat; Anne-Ségolène Cottereau; Sébastien Gaujoux; Florence Tenenbaum; Mathilde Sibony; Jérôme Bertherat; Rossella Libé; Martin Gaillard; Anne Jouinot; Guillaume Assié; Christine Hoeffel; Philippe Soyer; Anthony Dohan
Journal:  Cancers (Basel)       Date:  2022-01-23       Impact factor: 6.639

4.  Diagnostic dilemmas: a multi-institutional retrospective analysis of adrenal incidentaloma pathology based on radiographic size.

Authors:  David Zekan; Robert Scott King; Ali Hajiran; Apexa Patel; Samuel Deem; Adam Luchey
Journal:  BMC Urol       Date:  2022-04-30       Impact factor: 2.090

Review 5.  Approach to the Patient With Adrenal Incidentaloma.

Authors:  Irina Bancos; Alessandro Prete
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

6.  Assessment of Glycometabolism Impairment and Glucose Variability Using Flash Glucose Monitoring System in Patients With Adrenal Diseases.

Authors:  Minmin Han; Xiaoming Cao; Changjian Zhao; Luyang Yang; Nan Yin; Pengliang Shen; Jin Zhang; Fei Gao; Yi Ren; Dong Liang; Jing Yang; Yi Zhang; Yunfeng Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-25       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.